Early rhythm control for atrial fibrillation: looking cost-effective, at least from one direction

Europace. 2023 May 19;25(5):euad085. doi: 10.1093/europace/euad085.

Author

Daniel P Morin^{1

2}

Affiliations

¹ Department of Cardiology, Ochsner Medical Center, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
² Department of Cardiology, University of Queensland Ochsner Clinical School, 1514 Jefferson Highway, New Orleans, LA 70121, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / therapy
Cost-Benefit Analysis
Cost-Effectiveness Analysis
Humans

Substances

Anti-Arrhythmia Agents